Rapid Plasma Reagin (RPR) Test

Syphilis is one of the most common sexually transmitted diseases (STDs) caused by the bacteria Treponema pallidum. It can be transmitted through sexual contact with an infected person or from a pregnant person to their baby. Syphilis usually develops in stages, each with different signs and symptoms that can last for weeks, months, or even years. In the early stages, syphilis may not cause noticeable symptoms, but it can still be contagious and cause serious complications if left untreated. Therefore, it is important to screen for and diagnose syphilis as soon as possible.

Syphilis tests are used to detect antibodies in the blood that are produced by the immune system in response to the infection. There are two types of syphilis tests: nontreponemal tests and treponemal tests. Nontreponemal tests measure nonspecific antibodies that react with lipids (fats) released by damaged cells. These antibodies are not specific to syphilis and may also be present in other conditions, such as autoimmune diseases, other infections, and vaccinations. Therefore, nontreponemal tests are mainly used for screening and monitoring the treatment of syphilis. Treponemal tests measure specific antibodies that react only with Treponema pallidum antigens. These antibodies remain in the blood for life, even after successful treatment of syphilis. Therefore, treponemal tests are mainly used for confirming the diagnosis of syphilis and ruling out false-positive results from nontreponemal tests.

The most common nontreponemal tests are Rapid Plasma Reagin (RPR) and Venereal Disease Research Laboratory (VDRL) tests. Both tests are based on the principle of flocculation, which is the formation of clumps when antibodies bind to antigens. The RPR test uses cardiolipin-coated charcoal particles as antigens, which can be seen as black clumps against a white background without a microscope . The VDRL test uses cardiolipin-lecithin-cholesterol antigen, which requires a microscope to observe the clumps . Both tests require a drop of blood or plasma to be mixed with the antigen on a card or slide and rotated for a few minutes. A positive result indicates the presence of reagin antibodies in the sample, while a negative result indicates their absence.

Both RPR and VDRL tests are simple, fast, and inexpensive methods for screening syphilis. However, they have some limitations and differences. For example:

• RPR and VDRL tests may give false-negative results in early primary syphilis, late syphilis, or when there is a high concentration of antibodies that interfere with the reaction (prozone phenomenon) .
• RPR and VDRL tests may give false-positive results in other conditions that cause tissue damage or inflammation, such as viral infections (e.g., hepatitis, HIV), autoimmune diseases (e.g., lupus), pregnancy, malignancies, etc. .
• RPR and VDRL tests need to be confirmed by a treponemal test to establish a definitive diagnosis of syphilis .
• RPR test is more sensitive than VDRL test for detecting syphilis.
• RPR test does not require heating or fresh samples, while VDRL test does.
• RPR test can be performed without a microscope, while VDRL test requires one.
• VDRL test can be performed on cerebrospinal fluid (CSF) to diagnose neurosyphilis, while RPR test cannot .

In summary, RPR and VDRL tests are useful tools for screening and monitoring syphilis infection, but they need to be interpreted with caution and confirmed by a treponemal test. In addition, they should be performed along with a thorough medical history, physical examination, and risk assessment of the patient.

IgM and IgG are two types of immunoglobulins or antibodies that are produced by the immune system in response to foreign substances, such as bacteria, viruses, and other antigens. Antibodies are proteins that bind to specific parts of the antigens and help to eliminate them from the body.

IgM and IgG differ in several aspects, such as their structure, function, location, and timing of production.

Structure

IgM and IgG have different structures that affect their ability to bind to antigens and activate other immune cells. IgM is a pentamer, which means it consists of five identical units joined together. Each unit has two heavy chains and two light chains, forming a Y-shaped molecule. IgM has 10 antigen-binding sites, which gives it a high avidity or binding strength.

IgG is a monomer, which means it consists of one unit with two heavy chains and two light chains. IgG has only two antigen-binding sites, which gives it a lower avidity than IgM. However, IgG has four subclasses (IgG1, IgG2, IgG3, and IgG4) that have different properties and functions.

Function

IgM and IgG have different functions in the immune system. IgM is mainly responsible for the primary immune response, which is the first line of defense against a new infection or antigen exposure. IgM can activate the complement system, which is a group of proteins that enhance the killing of pathogens by antibodies. IgM can also agglutinate or clump together antigens, making them easier to be phagocytosed or engulfed by immune cells.

IgG is mainly responsible for the secondary immune response, which is the long-term protection against reinfection or re-exposure to the same antigen. IgG can also activate the complement system, but more importantly, it can opsonize or coat antigens, enhancing their phagocytosis by immune cells. IgG can also cross the placenta and provide passive immunity to the fetus.

Location

IgM and IgG have different locations in the body. IgM is mostly found in the blood and lymph fluid, where it circulates and encounters antigens. IgM can also be secreted by mucosal tissues, such as the respiratory and gastrointestinal tracts.

IgG is widely distributed throughout the body fluids, such as blood, lymph, cerebrospinal fluid (CSF), saliva, tears, and breast milk. IgG can also enter tissues and organs where it protects against infections.

Timing

IgM and IgG have different timing of production after antigen exposure. IgM is produced first as a short-term response to a new infection or antigen exposure. It increases for several weeks and then declines as IgG production begins.

IgG is produced later as a long-term response to an infection or antigen exposure. It rises a few weeks after it begins and then stabilizes at a constant level. The body retains a memory of the specific IgG antibodies that have been made and can rapidly produce more if exposed to the same antigen again.

The Rapid Plasma Reagin (RPR) test is a macroscopic, non-treponemal flocculation card test that detects antibodies produced against antigens released by damaged host cells in patients suffering from syphilis. Syphilis is a sexually transmitted infection (STI) caused by the spirochete bacterium Treponema pallidum.

The RPR test works by measuring the nonspecific antibodies that your body produces while fighting the infection. These antibodies are not specific to syphilis, but they react with cardiolipin, a lipid present in the cell membranes of humans and many bacteria. Cardiolipin is also released from damaged cells during syphilis infection.

In the test, the RPR antigen is mixed with unheated or heated serum or with unheated plasma on a plastic-coated card. The antigen used for detection contains 0.03% cardiolipin, 0.21% lecithin, and 0.9% cholesterol in addition to choline chloride, EDTA and charcoal particles. The charcoal particles help to visualize the reaction by showing up as black clumps against the white card.

If antibodies are present in the sample, they combine with the lipid particles of the antigen, causing them to agglutinate or clump together . This is called a positive or reactive result. If antibodies are not present, the test mixture is uniformly gray. This is called a negative or nonreactive result .

The RPR test is a quick and easy way to screen for syphilis. However, it cannot confirm the diagnosis of syphilis by itself, as it may give false-positive or false-negative results in some cases . Therefore, any reactive RPR test must be confirmed with a specific or treponemal test such as TPHA, FTA-ABS test . These tests detect antibodies that are specific to Treponema pallidum and can differentiate between active and past infections.

The RPR test can also be used to monitor the progress of treatment for syphilis. After a course of effective antibiotic therapy, the antibody levels should drop and the RPR test should become nonreactive or show a fourfold decrease in titer . A titer is the reciprocal of the highest dilution of the sample that shows a positive result. For example, if a sample shows a positive result at a 1:16 dilution but not at a 1:32 dilution, the titer is 16. A fourfold decrease in titer means that the titer has dropped from 16 to 4 or lower.

To perform the RPR test, you will need the following items:

• Patient`s serum or plasma: This is the blood sample that will be tested for syphilis antibodies. Serum is obtained by centrifuging whole blood after clotting, while plasma is obtained by centrifuging whole blood with an anticoagulant. Either serum or plasma can be used for the RPR test, but they should not be heated or frozen before testing.
• RPR antigen suspension: This is the reagent that contains the cardiolipin-lecithin-cholesterol antigen and charcoal particles that will react with syphilis antibodies in the patient`s sample. The antigen suspension should be stored at 2°C to 8°C and brought to room temperature before use. It should be mixed well by gentle inversion before dispensing.
• Control serum samples: These are samples of known reactivity that are used to check the validity of the test procedure and the antigen reagent. A positive control contains syphilis antibodies and should produce a reactive result, while a negative control does not contain syphilis antibodies and should produce a nonreactive result. Control samples should be treated in the same way as patient samples.
• Plastic-coated RPR cards: These are cards with 10 circles marked on them, where the test reactions will take place. The cards are coated with a special material that prevents the antigen suspension from spreading or drying out. The cards should be stored at room temperature and protected from light and moisture.
• Mechanical rotator: This is a device that rotates the RPR cards at a constant speed of 100 ± 2 rpm for 8 minutes during the test reaction. The rotator should be checked for proper speed and balance before use.
• Pipettes: These are instruments that are used to measure and transfer small volumes of liquids, such as serum, plasma, saline, and antigen suspension. Disposable pipettes or pipette tips should be used to avoid cross-contamination between samples and reagents.

These are the basic requirements for performing the RPR test. Depending on the method of testing (qualitative or quantitative), you may also need additional items such as saline, nonreactive serum diluent, humidifying cover, timer, and high-intensity light source.

The RPR test can be performed both qualitatively and quantitatively. Qualitative tests are used to screen for syphilis, while quantitative tests are used to measure the antibody titers and monitor the response to treatment. Those tests that are reactive by qualitative test are subjected to quantitative test to determine the antibody titers.

Qualitative Method

• Using a disposable pipette or a safety pipetting device, place one drop (50 µl) of the test specimen, positive and negative controls on separate reaction circles of the plastic-coated card .
• Once spread smoothly, add a drop of diluted antigen suspension to the measured volume of specimen, positive and negative controls. Do not spread or move the antigen .
• Place the card on an automatic rotator and rotate continuously at 100 ± 2 rpm for 8 minutes .
• Following rotation, perform a brief hand rotation and tilting of the card (three or four to-and-fro motions) to aid in differentiating nonreactive from minimally reactive results .
• Check for flocculation macroscopically under a high-intensity light source .

Quantitative Method

• Dilute to an endpoint titer all serum specimens with rough nonreactive results in the qualitative test. Test each specimen undiluted (1:1), and in 1:2, 1:4, 1:8, and 1:16 dilutions .
• Place 50 µl of 0.9% saline in circles numbered 2 through 5. Do not spread the saline .
• Using a pipette, place 50 µl of serum in circle 1 and 50 µl of serum in circle 2 .
• Mix the saline and the serum in circle 2 by drawing the mixture up and down in a pipette eight times avoiding bubble formation .
• Transfer 50 µl from circle 2 (1:2) to circle 3, and mix .
• Transfer 50 µl from circle 3 (1:4) to circle 4, and mix .
• Transfer 50 µl from circle 4 (1:8) to circle 5 (1:16), mix, and then discard the last 50 µl .
• Add exactly one free-falling drop (17 µl) of antigen suspension in each circle. Do not mix .
• Place the card on the rotator under the humidifying cover and rotate the card for 8 minutes at 100 ± 2 rpm .
• Immediately remove the card from the rotator; briefly rotate and tilt the card by hand (three or four to-and-fro motions) .
• If the highest dilution tested (1:16) is reactive, continue as follows:
  • Prepare a 1:50 dilution of nonreactive serum in 0.9% saline to be used for making 1:32 and higher dilutions of the specimen to be tested .
  • Prepare a 1:16 dilution of the test specimen by adding 0.1 ml of serum to 1.5 ml of 0.9% saline. Mix thoroughly.
  • Place 50 µl of the 1:50 nonreactive serum diluent in circles 2 through 5 of an RPR card.
  • Using a safety pipetting device with disposable tip, place 50 µl of the 1:16 dilution of the test specimen in circle 1 and 50 µl in circle 2.
  • Using the same pipette and tip, make serial twofold dilutions. Complete test as described in steps above.

The RPR test can be performed both qualitatively and quantitatively. A qualitative test gives a positive or negative result, while a quantitative test gives a numerical value of the antibody level (titer) in the blood.

Positive and Negative Tests

A positive test result means that the RPR antigen has reacted with the antibodies in the blood sample, forming visible clumps on the card. A negative test result means that no clumps have formed, indicating the absence of antibodies.

However, a positive or negative result does not necessarily confirm or rule out syphilis infection. There are several factors that can affect the accuracy of the RPR test, such as:

• The stage of syphilis: In early primary syphilis, the antibodies may not have developed yet, leading to a false-negative result. In late syphilis, the antibody level may decline, also causing a false-negative result.
• The presence of other conditions: Some diseases or conditions can cause false-positive results by producing antibodies that cross-react with the RPR antigen. These include HIV, Lyme disease, malaria, lupus, pregnancy, IV drug use, and tuberculosis.
• The prozone phenomenon: This occurs when there is a very high level of antibodies in the blood sample, which interferes with the formation of clumps. This can cause a false-negative result in some cases of secondary syphilis.

Therefore, any positive or negative RPR test result must be confirmed with a specific treponemal test, such as TPPA or FTA-ABS, which detects antibodies that are specific to Treponema pallidum, the causative agent of syphilis.

Quantitative Test and Titer

A quantitative test measures the amount of antibodies in the blood sample by diluting it until no clumps are formed. The titer is reported as the reciprocal of the highest dilution that shows a positive result. For example, if the highest dilution that shows clumping is 1:16, then the titer is 16.

The titer can be used to monitor the progress of syphilis infection and treatment. Generally, a higher titer indicates a more active infection, while a lower titer indicates a less active infection or an effective treatment. However, the titer can also vary depending on individual factors and immune response.

According to Healthline, some general guidelines for interpreting titers are:

• A fourfold increase in titer (e.g., from 8 to 32) may suggest a new infection, a reinfection, or a treatment failure.
• A fourfold decrease in titer (e.g., from 32 to 8) following treatment for early syphilis usually indicates that therapy was adequate.
• A stable or persistent titer (e.g., 16 for more than one year) may indicate latent syphilis or inadequate treatment response.
• A very high titer (e.g., >128) may indicate neurosyphilis or congenital syphilis.

However, these guidelines are not absolute and should be interpreted in conjunction with clinical findings and other laboratory tests. Some patients may have serofast reactions, which means that their titers do not decline after treatment despite being cured. Some patients may also have seroreversion reactions, which means that their titers become negative after treatment despite having residual infection.

Therefore, it is important to consult an expert in syphilis management before making any diagnosis or treatment decisions based on RPR test results.

The RPR test has several applications in the diagnosis and management of syphilis, as well as in the screening of high-risk populations. Some of the applications are:

• It is used mostly as the screening test for syphilitic infection. Combined with specific antibody testing, the RPR test allows confirming the diagnosis of active infection and starting treatment .
• Screening for syphilis is a routine part of pregnancy tests. This is because syphilis can cause serious complications for the mother and the baby, such as miscarriage, stillbirth, congenital syphilis, and neonatal death .
• The test for syphilis is also performed if being treated for another STI such as gonorrhea, infected with HIV, or if engaged in high-risk sexual activity.
• The RPR test can also be used to monitor the response to treatment for syphilis. A fourfold decrease in titer following treatment for early syphilis usually indicates that therapy was adequate. Conversely, a fourfold rise in titer in a repeat specimen may suggest an infection, a reinfection, or a treatment failure .
• The RPR test can also be used to investigate other treponemal diseases, such as yaws and pinta, which are endemic in some regions of the world and share similar antigens with syphilis .

The RPR test is a widely used screening test for syphilis and other treponemal diseases. It has several advantages over other methods of diagnosis, such as:

• It is effective, easy to perform and fast. The test can be done in a doctor`s office or a lab, and the results can be observed without the use of a microscope .
• It is readily available in kit form for purchase. The test does not require expensive equipment or reagents, and can be performed with minimal training.
• It is cost-effective. The RPR test is cheaper than other tests for syphilis, such as treponemal tests or dark-field microscopy. It also reduces the total healthcare cost by preventing complications and transmission of the disease by early detection and treatment.
• It can measure the antibody titer, which can be used to track the progress of the disease over time and its response to therapy . A fourfold rise or fall in titer can indicate a new infection, reinfection, treatment failure or success.
• It can detect syphilis effectively in patients without symptoms. The RPR test can be positive even if the patient does not have visible sores or rashes, which can occur in early or late stages of syphilis.
• It can also screen for other treponematose, such as yaws and pinta, which are endemic in some regions of the world. These diseases are caused by closely related bacteria to Treponema pallidum, and can also produce antibodies that react with the RPR antigen.

• The RPR test is not a definitive test for syphilis. It can only detect the presence of nonspecific antibodies that may be produced in response to various conditions, not just syphilis. Therefore, any positive RPR test must be confirmed by a more specific treponemal test, such as TPHA or FTA-ABS .
• The RPR test may give false-negative results in some cases, such as early primary syphilis, late syphilis, or prozone reaction (when high levels of antibodies interfere with the test reaction) . Therefore, a negative RPR test does not rule out syphilis completely, especially if there are clinical signs or risk factors for the infection.
• The RPR test may also give false-positive results in some cases, such as HIV, Lyme disease, malaria, lupus, pneumonia, IV drug use, tuberculosis, and other non-treponemal diseases . Therefore, a positive RPR test does not necessarily indicate syphilis infection, and may require further evaluation and testing.
• The RPR test cannot be used to test spinal fluids, as it may give unreliable results.
• The RPR test may be reactive in persons from areas where yaws, pinta, or nonvenereal syphilis is endemic . These are other treponemal infections that can cause similar antibodies to syphilis.
• The RPR test cannot distinguish between active and past infection. The antibodies detected by the test may persist for years after successful treatment or resolution of syphilis . Therefore, the RPR test cannot be used to monitor treatment response or cure. A fourfold decrease in antibody titers after treatment usually indicates adequate therapy, but this may take several months to occur .

We are Compiling this Section. Thanks for your understanding.